Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai
Description: Subject matter which contains a protein or its reaction product, e.g., peptides, peptones, fibrinogen, etc., wherein the protein molecule is not degraded to the constituent amino-acids.










Sub-classes under this class:

Class Number Class Name Patents
514/14 12 to 15 peptide repeating units in known peptide chain 1,156
514/13 16 to 24 peptide repeating units in known peptide chain 1,207
514/19 2 peptide repeating units in known peptide chain 1,352
514/12 25 or more peptide repeating units in known peptide chain structure 5,904
514/18 3 or 4 peptide repeating units in known peptide chain 1,666
514/17 5 or 6 peptide repeating units in known peptide chain 1,125
514/16 7 or 8 peptide repeating units in known peptide chain 1,087
514/15 9 to 11 peptide repeating units in known peptide chain 1,423
514/9 Cyclopeptides 730
514/8 Glycoprotein (carbohydrate containing) 2,102
514/6 Heavy metal containing (e.g., hemoglobin, etc.) 461
514/3 Insulin or derivative 639
514/5 Iodine containing 44
514/7 Phosphorus containing 211
514/21 Produced by or extracted from animal tissue 2,400


Patents under this class:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next

Patent Number Title Of Patent Date Issued
7514403 Process for the stabilization of proteins in an aqueous solution comprising cysteine in a concentration between 150 and 220mM Apr. 7, 2009
7514402 Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier Apr. 7, 2009
7514401 Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease Apr. 7, 2009
7514400 Synthetic mimics of mammalian cell surface receptors: method and compositions Apr. 7, 2009
7514399 Bonding tissues and cross-linking proteins with naphthalimide compounds Apr. 7, 2009
7514398 Growth factor complex Apr. 7, 2009
7514397 Methods for inhibition of membrane-fusion-associated events, including Hepatitis B virus transmission Apr. 7, 2009
7514101 Artificial bait based on a peptide attractant found in horseshoe crab eggs Apr. 7, 2009
7514092 Compositions and methods of their use for improving the condition and appearance of skin Apr. 7, 2009
7514082 Anti-viral VSF protein and hybridoma producing the same Apr. 7, 2009
7514077 Methods of antagonizing signal transduction in dorsal root ganglion cells with IL-31 antagonists Apr. 7, 2009
7514076 Antitumor agents Apr. 7, 2009
7514072 Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia Apr. 7, 2009
7511095 Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith Mar. 31, 2009
7511019 Method of treating coronary artery disease by administering FGF-4 Mar. 31, 2009
7511017 Methods of treatment with TNFR5 Mar. 31, 2009
7511012 Myostatin binding agents Mar. 31, 2009
7511011 Synthetic lipid mixtures for the preparation of a reconstituted surfactant Mar. 31, 2009
7511010 Pharmaceutical or cosmetic composition and use of a PKC inhibitor with an MMP inhibitor for inhibiting Langerhans' cell migration Mar. 31, 2009
7511009 Retinal pigmented epithelium derived neurotrophic factor Mar. 31, 2009
7510840 Method of inhibiting growth or survival of a cell by providing an anti-108P5H8 antibody Mar. 31, 2009
7510720 Vaccine to control equine protozoal myeloencephalitis in horses Mar. 31, 2009
7507745 Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins Mar. 24, 2009
7507716 Method for treating pain with prolactin antagonists Mar. 24, 2009
7507710 Anti-amyloid immunogenic compositions, methods and uses Mar. 24, 2009
7507709 Synergistic effects of OP/BMP morphogens and GDNF/NGF neurotrophic factors Mar. 24, 2009
7507708 Antitumoral compounds Mar. 24, 2009
7507707 Methods of inducing ovulation using a non-polypeptide camp level modulator Mar. 24, 2009
7507706 Cytokine receptor chain Mar. 24, 2009
7507705 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections Mar. 24, 2009
7507419 Topically applied Clostridium botulinum toxin compositions and treatment methods Mar. 24, 2009
7507413 Albumin fusion proteins Mar. 24, 2009
7504379 Protection of cardiac myocardium Mar. 17, 2009
7504375 Antimicrobial polypeptides Mar. 17, 2009
7504374 Method for inducing deposition and maturation of bone comprising a co-therapeutic regimen of LMP-1 and BMP-2 Mar. 17, 2009
7504110 Protein-based Streptococcus pneumoniae vaccines Mar. 17, 2009
7504106 Method and composition for treatment of renal failure with antibodies and their equivalents as partial or complete replacement for dialysis Mar. 17, 2009
7504096 Methods for in vitro fertilization Mar. 17, 2009
7504086 Structure and method for releasing substance therefrom Mar. 17, 2009
7501396 Methods for treating joint pain using poly-gamma-glutamic acid Mar. 10, 2009
7501395 Method of screening for antianxiety drugs Mar. 10, 2009
7501392 Method of treatment of viral hepatitis C with interferon alpha 5 Mar. 10, 2009
7501391 Treatment of transplant survival Mar. 10, 2009
7501134 Microparticles with adsorbed polypeptide-containing molecules Mar. 10, 2009
7501132 Multiple antigenic peptides immunogenic against Streptococcus pneumonia Mar. 10, 2009
7501125 Vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent Mar. 10, 2009
7498310 Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by UV Mar. 3, 2009
7498306 Peptides binding to the phosphatase 2A protein Mar. 3, 2009
7498299 Procollagen (III) propeptides and related substances for treating fibrotic diseases Mar. 3, 2009
7498298 Monomethylvaline compounds capable of conjugation to ligands Mar. 3, 2009

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next










 
 
  Recently Added Patents
User-initiated quality of service modification in a mobile device
Imidazole derivatives used as TAFIa inhibitors
Switching device, switch control method, and storage system
Motor assembly
Multi-state DC-DC converter having undirectional switches
Reverse mapping method and apparatus for form filling
Semiconductor memory device
  Randomly Featured Patents
Optical storage medium utilizing electron trapping film layers sandwiched with electrodes
Multi-sided tapered dice
Mechanism and method to select a time delay in response to a collision
Automated damping port rodder
1,2,3,4,5,6-He xahydro-3-(3-methyl-2-butenyl)-6-methyl-11(EQ)-hydroxy-11-methyl-2,6-meth ano-3-benzazocine
Methods and systems for treating ischemia
Providing collection transparency information to an end user to achieve a guaranteed quality document search and production in electronic data discovery
Fiber optic sensing apparatus for detecting a fracture in a metallic workpiece and an associated method of attaching a fiber optic sensing element to the metallic workpiece
Wavelength-tunable optical ring resonators
Retaining microfluidic microcavity and other microfluidic structures